Interaction of ω-3 polyunsaturated fatty acids with radiation therapy in two different colorectal cancer cell lines

Clinical Nutrition

Volumn 33, Issue 1, 2014, Pages 164-170

  Cai, Fang ^a   Sorg, Olivier ^b   Granci, Virginie ^a   Lecumberri, Elena ^a   Miralbell, Raymond ^a   Dupertuis, Yves M ^a   Pichard, Claude ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

3 polyunsaturated fatty acids; Docosahexaenoic acid; Eicosapentaenoic acid; Human colorectal adenocarcinoma; Lipid peroxidation; Radiation therapy

Indexed keywords

CYCLOOXYGENASE 2; DOCOSAHEXAENOIC ACID; HEAT SHOCK PROTEIN 70; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALONALDEHYDE; OMEGA 3 FATTY ACID; PEROXIDE; PROTEIN BAX; PROTEIN BCL 2; RADIOSENSITIZING AGENT; SYNAPTOTAGMIN I;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL EFFECTIVENESS; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MOLECULAR INTERACTION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RADIATION DOSE; RADIOSENSITIVITY; RADIOSENSITIZATION; SENSITIVITY ANALYSIS; UPREGULATION; WESTERN BLOTTING; X RAY;

2,4-DINITROPHENYLHYDRAZINE; COLORECTAL ADENOCARCINOMA; CRC; DHA; DNPH; DOCOSAHEXAENOIC ACID; EDTA; EICOSAPENTAENOIC ACID; EPA; ETHYLENEDIAMINETETRAACETIC ACID; FACS; FITC; FLUORESCEIN ISOTHIOCYANATE; FLUORESCENCE-ACTIVATED CELL SORTING; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; HPLC; HUMAN COLORECTAL ADENOCARCINOMA; LIPID PEROXIDATION; MALONDIALDEHYDE; MDA; PBS; PHOSPHATE-BUFFERED SALINE; RADIATION THERAPY; RT; SDS-PAGE; SODIUM DODECYL SULFATE-POLYACRYLAMIDE GEL ELECTROPHORESIS; Ω-3 POLYUNSATURATED FATTY ACIDS; Ω-3 PUFAS;

APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; COLORECTAL NEOPLASMS; FATTY ACIDS, OMEGA-3; HT29 CELLS; HUMANS; LIPID PEROXIDATION; MALONDIALDEHYDE; NF-KAPPA B; RADIOTHERAPY;

EID: 84892542245     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2013.04.005     Document Type: Article

References (32)

1. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010 Sep-Oct, 60(5):277-300.
2. Andre N., Schmiegel W. Chemoradiotherapy for colorectal cancer. Gut 2005 Aug, 54(8):1194-1202.
3. Rose D.P., Connolly J.M. Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Ther 1999 Sep, 83(3):217-244.
4. Rao C.V., Hirose Y., Indranie C., Reddy B.S. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res 2001 Mar 1, 61(5):1927-1933.
5. Germain E., Chajes V., Cognault S., Lhuillery C., Bougnoux P. Enhancement of doxorubicin cytotoxicity by polyunsaturated fatty acids in the human breast tumor cell line MDA-MB-231: relationship to lipid peroxidation. Int J Cancer 1998 Feb 9, 75(4):578-583.
6. Benais-Pont G., Dupertuis Y.M., Kossovsky M.P., Nouet P., Allal A.S., Buchegger F., et al. omega-3 polyunsaturated fatty acids and ionizing radiation: combined cytotoxicity on human colorectal adenocarcinoma cells. Nutrition 2006 Sep, 22(9):931-939.
7. Bougnoux P., Hajjaji N., Maheo K., Couet C., Chevalier S. Fatty acids and breast cancer: sensitization to treatments and prevention of metastatic re-growth. Prog Lipid Res 2010 Jan, 49(1):76-86.
8. Calviello G., Serini S., Piccioni E., Pessina G. Antineoplastic effects of n-3 polyunsaturated fatty acids in combination with drugs and radiotherapy: preventive and therapeutic strategies. Nutr Cancer 2009, 61(3):287-301.
9. Colas S., Maheo K., Denis F., Goupille C., Hoinard C., Champeroux P., et al. Sensitization by dietary docosahexaenoic acid of rat mammary carcinoma to anthracycline: a role for tumor vascularization. Clin Cancer Res 2006 Oct 1, 12(19):5879-5886.
10. Bougnoux P., Germain E., Chajes V., Hubert B., Lhuillery C., Le Floch O., et al. Cytotoxic drugs efficacy correlates with adipose tissue docosahexaenoic acid level in locally advanced breast carcinoma. Br J Cancer 1999 Apr, 79(11-12):1765-1769.
11. Habermann N., Christian B., Luckas B., Pool-Zobel B.L., Lund E.K., Glei M. Effects of fatty acids on metabolism and cell growth of human colon cell lines of different transformation state. Biofactors 2009 Sep-Oct, 35(5):460-467.
12. Kim S., Wu H.G., Shin J.H., Park H.J., Kim I.A., Kim I.H. Enhancement of radiation effects by flavopiridol in uterine cervix cancer cells. Cancer Res Treat 2005 Jun, 37(3):191-195.
13. Sim A.S., Salonikas C., Naidoo D., Wilcken D.E. Improved method for plasma malondialdehyde measurement by high-performance liquid chromatography using methyl malondialdehyde as an internal standard. JChromatogr B Analyt Technol Biomed Life Sci 2003 Mar 5, 785(2):337-344.
14. Bougnoux P., Hajjaji N., Ferrasson M.N., Giraudeau B., Couet C., Le Floch O. Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial. Br J Cancer 2009 Dec 15, 101(12):1978-1985.
15. Wen B., Deutsch E., Opolon P., Auperin A., Frascogna V., Connault E., et al. n-3 polyunsaturated fatty acids decrease mucosal/epidermal reactions and enhance antitumour effect of ionising radiation with inhibition of tumour angiogenesis. Br J Cancer 2003 Sep 15, 89(6):1102-1107.
16. Colas S., Paon L., Denis F., Prat M., Louisot P., Hoinard C., et al. Enhanced radiosensitivity of rat autochthonous mammary tumors by dietary docosahexaenoic acid. Int J Cancer 2004 Apr 10, 109(3):449-454.
17. Cai F., Dupertuis Y.M., Pichard C. Role of polyunsaturated fatty acids and lipid peroxidation on colorectal cancer risk and treatments. Curr Opin Clin Nutr Metab Care 2012 Mar, 15(2):99-106.
18. Lu X., Yu H., Ma Q., Shen S., Das U.N. Linoleic acid suppresses colorectal cancer cell growth by inducing oxidant stress and mitochondrial dysfunction. Lipids Health Dis 2010, 9:106.
19. Song K.S., Jing K., Kim J.S., Yun E.J., Shin S., Seo K.S., et al. Omega-3-polyunsaturated fatty acids suppress pancreatic cancer cell growth invitro and invivo via downregulation of Wnt/Beta-catenin signaling. Pancreatology 2011, 11(6):574-584.
20. Serini S., Fasano E., Piccioni E., Monego G., Cittadini A.R., Celleno L., et al. DHA induces apoptosis and differentiation in human melanoma cells invitro: involvement of HuR-mediated COX-2 mRNA stabilization and beta-catenin nuclear translocation. Carcinogenesis 2012 Jan, 33(1):164-173.
21. Courtney E.D., Matthews S., Finlayson C., Di Pierro D., Belluzzi A., Roda E., et al. Eicosapentaenoic acid (EPA) reduces crypt cell proliferation and increases apoptosis in normal colonic mucosa in subjects with a history of colorectal adenomas. Int J Colorectal Dis 2007 Jul, 22(7):765-776.
22. Kelly P.N., Strasser A. The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy. Cell Death Differ 2011 Sep, 18(9):1414-1424.
23. Gehrmann M., Radons J., Molls M., Multhoff G. The therapeutic implications of clinically applied modifiers of heat shock protein 70 (Hsp70) expression by tumor cells. Cell Stress & Chaperones 2008 Spring, 13(1):1-10.
24. Magne N., Toillon R.A., Bottero V., Didelot C., Houtte P.V., Gerard J.P., et al. NF-kappaB modulation and ionizing radiation: mechanisms and future directions for cancer treatment. Cancer Lett 2006 Jan 18, 231(2):158-168.
25. Smirnov A.S., Ruzov A.S., Budanov A.V., Prokhortchouk A.V., Ivanov A.V., Prokhortchouk E.B. High constitutive level of NF-kappaB is crucial for viability of adenocarcinoma cells. Cell Death Differ 2001 Jun, 8(6):621-630.
26. Eschrich S., Zhang H., Zhao H., Boulware D., Lee J.H., Bloom G., et al. Systems biology modeling of the radiation sensitivity network: a biomarker discovery platform. Int J Radiat Oncol Biol Phys 2009 Oct 1, 75(2):497-505.
27. Sandur S.K., Deorukhkar A., Pandey M.K., Pabon A.M., Shentu S., Guha S., et al. Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-kappaB activity. Int J Radiat Oncol Biol Phys 2009 Oct 1, 75(2):534-542.
28. Zand H., Rahimipour A., Salimi S., Shafiee S.M. Docosahexaenoic acid sensitizes Ramos cells to Gamma-irradiation-induced apoptosis through involvement of PPAR-gamma activation and NF-kappaB suppression. Mol Cell Biochem 2008 Oct, 317(1-2):113-120.
29. Greenhough A., Smartt H.J., Moore A.E., Roberts H.R., Williams A.C., Paraskeva C., et al. The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis 2009 Mar, 30(3):377-386.
30. Ritchie S.A., Jayasinghe D., Davies G.F., Ahiahonu P., Ma H., Goodenowe D.B. Human serum-derived hydroxy long-chain fatty acids exhibit anti-inflammatory and anti-proliferative activity. JExp Clin Cancer Res 2011, 30:59.
31. Vinogradova Y., Coupland C., Hippisley-Cox J. Exposure to cyclooxygenase-2 inhibitors and risk of cancer: nested case-control studies. Br J Cancer 2011 Jul 26, 105(3):452-459.
32. Avery-Kiejda K.A., Zhang X.D., Adams L.J., Scott R.J., Vojtesek B., Lane D.P., et al. Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin. Clin Cancer Res 2008 Mar 15, 14(6):1659-1668.